Siamab Therapeutics financial update

Siamab Therapeutics Inc., Cambridge, Mass. Business: Cancer, Antibodies Date announced: 2014-07-10 Note: Siamab (formerly Sialix) raised an additional $2 million in a series B round, bringing the tota...